background

Technology

At Petra Biosystems, our technology is built on a cutting-edge microfluidic platform designed to provide real-time, continuous monitoring of critical biomarkers in patients

Platform Overview

Our microfluidic system is designed for continuous bedside monitoring, offering rapid measurements with minimal sample requirements. The platform integrates advanced sensors within a compact, automated chip, ensuring that clinicians can track patient status in real time without repeated blood draws. This capability is particularly critical for patients at risk of sepsis, systemic inflammatory response syndrome (SIRS), and cytokine storms, where rapid physiological changes demand timely intervention.

Our Microfluidic Platform

At Petra Biosystems, our technology is built on a cutting-edge microfluidic platform designed to provide real-time, continuous monitoring of critical biomarkers in patients. By leveraging the precision and scalability of microfluidics, our platform delivers actionable insights from very small blood volumes, enabling timely clinical decisions and improving patient outcomes.

Analytes We Monitor

These biomarkers play critical roles in cellular signaling, inflammation, and oxidative stress, which provide context for metabolic state and organ function.

service

Physiological parameters

  • Lactate

  • C-reactive protein (CRP)

  • Procalcitonin (PCT)

service

Inflammatory & Metabolic Markers

  • Glucose

  • pH

  • Temperature

service

Gasotransmitters

  • Lactate

  • C-reactive protein (CRP)

  • Procalcitonin (PCT)

How It Works

Multiple sensors integration into a single, compact device enables multiplexed analysis.

service
+

Visual dashboards can display trends, alerting clinicians to early signs of critical disease detection.

service
+

Advanced data processing algorithms convert raw sensor signals into real-time, clinically actionable information.

service
+

Blood samples are drawn minimally and flow through microchannels, where each sensor measures specific analytes continuously

Clinical Focus – Critical Diseases

Petra Biosystems’ microfluidic platform is designed to provide continuous, real-time monitoring of critical biomarkers, enabling clinicians to make faster, more informed decisions. By addressing gaps in current diagnostic methods, our technology supports a wide range of applications in healthcare, from intensive care units to clinical research and future personalized medicine initiatives.

Sepsis

Cytokine Storms

Sepsis

Systemic Inflammatory Response Syndrome (SIRS)

Sepsis

Sepsis

Why we stand apart

Petra Biosystems’ platform stands apart due to its combination of speed, accuracy, and versatility

service
Rapid measurement

Detects physiological changes early, enabling faster and more effective interventions.

service
Real-time data integration

Provides continuous monitoring and clear trend visualization for informed clinical decisions.

 

service
Multiplexing capability

Measures multiple biomarkers simultaneously from a single sample, enhancing efficiency.

service
ICU compatibility

Compact, automated, and designed to integrate with existing critical care workflows without disruption.

service
User-friendly interface

Real-time monitoring at a glance — improving diagnosis and supporting immediate patient care.

By bringing together microfluidics, biosensing, and data analytics, our platform provides a unique solution for proactive, patient-centric care in intensive care units.

Technology

Whom We Serve

service

ICU Patient Monitoring

The platform integrates seamlessly into ICU workflows, offering continuous bedside monitoring that reduces the need for repeated blood draws while providing a comprehensive view of patient health.

service

Emergency & Trauma Care

In high-pressure emergency or trauma settings, rapid decision-making is crucial. Real-time biomarker monitoring supports faster triage and targeted treatment, helping clinicians prioritize critical interventions.

service

Clinical Trials & Research Labs

Our technology also serves as a powerful research tool for studying disease progression, evaluating new therapies, and validating biomarkers. Multiplexed measurement capabilities allow researchers to collect robust, high-resolution data in real time.

service

Future Expansion

Looking ahead, our platform has the potential for personalized medicine applications and remote patient monitoring, enabling continuous health assessment outside the hospital and proactive management of high-risk populations.